Deluque Amanda Lima, Dimke Henrik, Alexander R Todd
Department of Pediatrics, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
Nephrol Dial Transplant. 2025 Feb 28;40(3):435-445. doi: 10.1093/ndt/gfae204.
Calcium (Ca2+) is an essential divalent cation involved in many bodily functions including bone composition, cell growth and division, blood clotting, and muscle contraction. The bone, intestine and kidneys are important for the maintenance of Ca2+ homeostasis. Ninety-nine percent of body Ca2+ is stored in the skeleton as hydroxyapatite. The small, and to a lesser extent the large intestine absorbs Ca2+ from the diet. Once in the circulation, Ca2+ is filtered by the glomerulus and the majority, >95%, is reabsorbed along the nephron. The remainder is excreted in the urine. Two general (re)absorptive pathways contribute to the vectorial transport of Ca2+ across renal and intestinal epithelia: (i) a paracellular pathway, which is reliant on claudins in the tight junction of epithelium and the electrochemical gradient, and (ii) a transcellular pathway, which requires different influx, intracellular buffering/shuttling and basolateral efflux mechanisms, to actively transport Ca2+ across the epithelial cell. Blood Ca2+ levels are maintained by hormones including parathyroid hormone, 1,25-dihydroxyvitamin D3 and fibroblast growth factor 23, and through effects of Ca2+-sensing receptor (CaSR) signaling. Disruption of Ca2+ homeostasis can result in altered blood Ca2+ levels and/or hypercalciuria, the latter is a phenomenon closely linked to the formation of kidney stones. Genetic alterations affecting renal Ca2+ handling can cause hypercalciuria, an area of expanding investigation. This review explores the molecular mechanisms governing Ca2+ homeostasis by the intestine and kidneys and discusses clinical aspects of genetic disorders associated with Ca2+-based kidney stone disease.
钙(Ca2+)是一种必需的二价阳离子,参与许多身体功能,包括骨骼组成、细胞生长和分裂、血液凝固以及肌肉收缩。骨骼、肠道和肾脏对于维持Ca2+稳态至关重要。人体99%的Ca2+以羟基磷灰石的形式储存在骨骼中。小肠以及在较小程度上大肠从饮食中吸收Ca2+。一旦进入循环系统,Ca2+由肾小球滤过,大部分(>95%)沿肾单位被重吸收。其余部分则随尿液排出。两种一般的(再)吸收途径有助于Ca2+跨肾脏和肠道上皮细胞的矢量运输:(i)细胞旁途径,它依赖于上皮紧密连接中的紧密连接蛋白和电化学梯度;(ii)跨细胞途径,它需要不同的流入、细胞内缓冲/穿梭和基底外侧流出机制,以主动将Ca2+运输穿过上皮细胞。血钙水平由包括甲状旁腺激素、1,25-二羟基维生素D3和成纤维细胞生长因子23在内的激素维持,并通过Ca2+感知受体(CaSR)信号传导的作用来维持。Ca2+稳态的破坏可导致血钙水平改变和/或高钙尿症,后者是一种与肾结石形成密切相关的现象。影响肾脏Ca2+处理的基因改变可导致高钙尿症,这是一个正在不断深入研究的领域。本综述探讨了肠道和肾脏控制Ca2+稳态的分子机制,并讨论了与钙基肾结石疾病相关的遗传疾病的临床方面。